Back to COLL
LINDEN ADVISORS LP COLL Position History
Collegium Pharmaceutical, Inc. • Healthcare
Quarters held
4
Latest value
$136.8M
Q3 2026
Peak value
$190.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $190.4M |
| Q1 2026 | $157.7M |
| Q2 2026 | $171.7M |
| Q3 2026 | $136.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $136.8M | 138.69M | — | — |
| Q2 2026 | $171.7M | 139.19M | — | — |
| Q1 2026 | $157.7M | 135.69M | — | — |
| Q4 2025 | $190.4M | 134.69M | — | — |
Other funds holding COLL
$160.1M
$134.2M
$114.2M
$81.1M
Other LINDEN ADVISORS LP positions
LITE
$2.1BLUMENTUM HOLDINGS INC 0.375 03/15/2032 144A
LITE
$1.5BLUMENTUM HOLDINGS INC 0.5 06/15/2028
LITE
$843.6MLUMENTUM HOLDINGS INC 1.5 12/15/2029
VSH
$829.5MVISHAY INTERTECHNOLOGY 2.25 09/15/2030
LITE
$807.1MLUMENTUM HOLDINGS INC 0.5 06/15/2028
LEU
$644MCENTRUS ENERGY CORP 2.25 11/01/2030
SITM
$624.9MSITIME 0 06/15/2031
MKSI
$593.3MMKS INC 1.25 06/01/2030